Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Direct costs of preventive headache treatments: comparison of behavioral and pharmacologic approaches.

Schafer AM, Rains JC, Penzien DB, Groban L, Smitherman TA, Houle TT.

Headache. 2011 Jun;51(6):985-91. doi: 10.1111/j.1526-4610.2011.01905.x.

PMID:
21631481
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.

Pradalier A, Auray JP, El Hasnaoui A, Alzahouri K, Dartigues JF, Duru G, Henry P, Lantéri-Minet M, Lucas C, Chazot G, Gaudin AF.

Pharmacoeconomics. 2004;22(15):985-99.

PMID:
15449963
[PubMed - indexed for MEDLINE]
3.

Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, Reed M, Lipton RB.

Headache. 2009 Apr;49(4):498-508. doi: 10.1111/j.1526-4610.2009.01369.x. Epub 2009 Feb 25.

PMID:
19245386
[PubMed - indexed for MEDLINE]
4.

Cost considerations in headache treatment. Part 1: Prophylactic migraine treatment.

Adelman JU, Von Seggern R.

Headache. 1995 Sep;35(8):479-87.

PMID:
7591743
[PubMed - indexed for MEDLINE]
5.

The relationship of antidepressant prescribing concentration to treatment duration and cost.

Hodgkin D, Merrick EL, Hiatt D.

J Ment Health Policy Econ. 2012 Mar;15(1):3-11.

PMID:
22611088
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.

Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K.

Am J Psychiatry. 2005 Sep;162(9):1628-36.

PMID:
16135621
[PubMed - indexed for MEDLINE]
7.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
8.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
9.

Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).

Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM.

Headache. 2011 Jul-Aug;51(7):1058-77. doi: 10.1111/j.1526-4610.2011.01945.x.

PMID:
21762134
[PubMed - indexed for MEDLINE]
10.

Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients.

Schim J.

Curr Med Res Opin. 2004 Jan;20(1):49-53. Review.

PMID:
14741072
[PubMed - indexed for MEDLINE]
11.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.

PMID:
12065068
[PubMed - indexed for MEDLINE]
Free Article
12.

Reduction of medication costs after detoxification for medication-overuse headache.

Shah AM, Bendtsen L, Zeeberg P, Jensen RH.

Headache. 2013 Apr;53(4):665-72. doi: 10.1111/head.12031. Epub 2012 Dec 20.

PMID:
23278344
[PubMed - indexed for MEDLINE]
14.

Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.

Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, Fisher P, Van Haselen R, Wonderling D, Grieve R.

Health Technol Assess. 2004 Nov;8(48):iii, 1-35. Review.

PMID:
15527670
[PubMed - indexed for MEDLINE]
Free Article
15.

Behavioral treatment strategies for migraine and tension-type headache: a review of the evidence and future directions.

Rains JC, Penzien DB.

Expert Rev Neurother. 2002 Sep;2(5):749-60. doi: 10.1586/14737175.2.5.749.

PMID:
19810992
[PubMed]
16.

Improving care through health economics analyses: cost of illness and headache.

Mennini FS, Gitto L, Martelletti P.

J Headache Pain. 2008 Aug;9(4):199-206. doi: 10.1007/s10194-008-0051-9. Epub 2008 Jul 5. Review.

PMID:
18604472
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Screening and Interventions for Childhood Overweight [Internet].

Whitlock EP, Williams SB, Gold R, Smith P, Shipman S.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul.

PMID:
20722132
[PubMed]
Books & Documents
18.

Cost assessment of headache in childhood and adolescence: preliminary data.

Mazzotta G, Gallai B, Mattioni A, Floridi F, Foti F, Allegretti M, D'Angelo R.

J Headache Pain. 2005 Sep;6(4):281-3.

PMID:
16362687
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cost considerations in headache treatment. Part 2: Acute migraine treatment.

Von Seggern RL, Adelman JU.

Headache. 1996 Sep;36(8):493-502.

PMID:
8824005
[PubMed - indexed for MEDLINE]
20.

Behavioral interventions for tension-type headache: overview of current therapies and recommendation for a self-management model for chronic headache.

Penzien DB, Rains JC, Lipchik GL, Creer TL.

Curr Pain Headache Rep. 2004 Dec;8(6):489-99. Review.

PMID:
15509464
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk